Please login or register to print this page.

Clinical Articles, Lead Article

Left atrial appendage closure noninferior to warfarin

The “local” strategy of left atrial appendage (LAA) closure is noninferior to “systemic” anticoagulation with warfarin, according to results from the PROTECT AF study1 published recently in Circulation.

The multicenter PROTECT AF study was conducted to determine whether percutaneous LAA closure with a filter device (Watchman) was noninferior to warfarin for stroke prevention in atrial fibrillation (AF).

Researchers randomised 707 patients with nonvalvular AF and at least one risk factor (age >75, hypertension, heart failure, diabetes or prior stroke/transient ischaemic attack) to either the Watchman device (n = 463) or continued warfarin (n = 244) in a 2:1 ratio.

After device implantation, warfarin was continued for ~45 days, followed by clopidogrel for 4.5 months and lifelong aspirin. Study discontinuation rates were 15.3% (71/463) and 22.5% (55/244) for the Watchman and warfarin groups respectively. The time in therapeutic range for the warfarin group was 66%. The composite primary efficacy endpoint included stroke, systemic embolism and cardiovascular death, and the primary analysis was by intention-to-treat.

After 1,588 patient-years of follow-up (mean 2.3±1.1 years), the primary efficacy event rates were 3.0% and 4.3% (percent per 100-patient years) in the Watchman and warfarin groups, respectively, meeting the criteria for non-inferiority (probability of non-inferiority >0.999). There were more primary safety events in the Watchman group (5.5%/y, 95% CI 4.2-7.1%/y) than in the control group (3.6%/y; 95% CI 2.2-5.3%/y; RR 1.53, 95% CI 0.95-2.70).

PROTECT AF has, for the first time, implicated the LAA in the pathogenesis of stroke in AF, the authors conclude.

References

1. Reddy BY, Doshi SK, Siever H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3 year Follow-up of the PROTECT AF trial. Circulation 2013. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.114389

Published on: January 25, 2013

Members Area

Log in or Register now.

 For healthcare professionals only
Angina book sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.